Cohen & Steers (CNS) COO receives 259 dividend-linked stock units

Rhea-AI Filing Summary

Cohen & Steers, Inc. Chief Operating Officer and Executive Vice President Adam M. Derechin received an automatic equity-based compensation award tied to the company’s first quarter 2026 dividend. He acquired 259 shares of common stock at no cost, representing dividend equivalent restricted stock units accrued on unvested awards granted in January 2023, 2024, 2025 and 2026. After this routine compensation-related acquisition, he directly holds 536,071 shares of Cohen & Steers common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DERECHIN ADAM M

Role Chief Operating Officer, EVP

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	259	$0.00	--

Holdings After Transaction: Common Stock — 536,071 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DERECHIN ADAM M

(Last) (First) (Middle)

1166 AVENUE OF THE AMERICAS

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer, EVP

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		A		259(1)	A	$0	536,071	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's first quarter 2026 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2023, January 2024, January 2025 and January 2026.

Remarks:

	/s/ Brian W. Heller, Attorney-in-Fact	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CNS executive Adam M. Derechin report on this Form 4?

Adam M. Derechin reported acquiring 259 shares of Cohen & Steers common stock. The shares were issued as dividend equivalent restricted stock units tied to the company’s first quarter 2026 dividend on previously granted unvested restricted stock units.

Was the CNS Form 4 transaction an open-market purchase or a compensation award?

The Form 4 for Cohen & Steers (CNS) shows a compensation-related award, not an open-market purchase. The 259 shares were granted at a price of $0.00 per share as dividend equivalent restricted stock units on earlier unvested equity awards.

How many CNS shares does Adam M. Derechin hold after this reported transaction?

Following the reported acquisition, Adam M. Derechin beneficially owns 536,071 shares of Cohen & Steers common stock directly. This total reflects his position after receiving 259 additional dividend equivalent restricted stock units credited in connection with the first quarter 2026 dividend.

What is a dividend equivalent restricted stock unit in the context of CNS?

For Cohen & Steers (CNS), dividend equivalent restricted stock units represent additional stock units credited when cash dividends are paid. They accrue on outstanding unvested restricted stock units so award holders receive comparable value to shareholders while those underlying awards remain unvested.

Which prior CNS equity grants generated the new dividend equivalent units for Adam M. Derechin?

The 259 dividend equivalent restricted stock units accrued on unvested restricted stock units originally granted to Adam M. Derechin in January 2023, January 2024, January 2025 and January 2026. They were credited in connection with Cohen & Steers’ first quarter 2026 dividend.